Suchergebnisse - "anticancer agents"

PubPharm (2.207)

71

Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2023

von Tekeli, T. | Akocak, S. | Petreni, A. | +3

72

Protein-Porphyrin Complex Photosensitizers for Anticancer and Antimicrobial Photodynamic Therapies

enthalten in: ChemMedChem | 2023

von Yamada, T. | Komatsu, T.

73

Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors : synthesis, biological evaluations, and molecular dynamic simulations

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2023

von Haffez, H. | Elsayed, N. | Ahmed, M. | +9

74

Patient Adherence to Oral Anticancer Agents : A Mapping Review of Supportive Interventions

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Ahmed, S. | Loiselle, C.

75

Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer : a comprehensive review of preclinical and clinical studies

enthalten in: Critical reviews in food science and nutrition | 2023

von Singla, R. | Wang, X. | Gundamaraju, R. | +10

76

Synthesis, crystal structure and molecular docking study of novel isoxazole derivatives as CYP450 inhibitors in search of anticancer agents

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Wazalwar, S. | Banpurkar, A. | Perdih, F.

77

Herbal Melanin Inhibits Real-Time Cell Proliferation, Downregulates Anti-Apoptotic Proteins and Upregulates Pro-Apoptotic p53 Expression in MDA-MB-231 and HCT-116 Cancer Cell Lines

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Rajabathar, J. | Al-Lohedan, H. | Arokiyaraj, S. | +4

78

Anticarcinogenic Potency of EF24 : An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery

enthalten in: Cancers | 2023

von Sazdova, I. | Keremidarska-Markova, M. | Dimitrova, D. | +8

79

Design, Synthesis, In Vitro, and In Silico Studies of New N5-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Zaki, W. | El-Sayed, S. | Alswah, M. | +8

80

Bispecific G-quadruplexes as inhibitors of cancer cells growth

enthalten in: Biochimie | 2023

von Roxo, C. | Zielińska, K. | Pasternak, A.